Related Experiment Video
Updated: Feb 14, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Neonatal Diabetes Mellitus: An Update on Diagnosis and Management
Michelle Blanco Lemelman1, Lisa Letourneau2, Siri Atma W Greeley3
1Section of Adult and Pediatric Endocrinology, Diabetes, and Metabolism, MC 5053, 5841 South Maryland Avenue, Chicago, IL 60637, USA.
Insights
Neonatal diabetes mellitus, often caused by genetic defects, requires prompt diagnosis and genetic testing. Early sulfonylurea treatment can improve outcomes for specific types of this condition.
Area of Science:
- Endocrinology
- Genetics
- Neonatology
Background:
- Neonatal diabetes mellitus (NDM) is a rare condition occurring within the first six months of life.
- It is frequently caused by a monogenic defect, necessitating early identification.
- Distinguishing NDM from other neonatal hyperglycemia causes is critical.
Purpose of the Study:
- To review the diagnostic strategies for neonatal diabetes mellitus.
- To discuss the various mutation types associated with NDM.
- To outline management approaches and predict clinical outcomes.
Main Methods:
- Literature review of diagnostic approaches.
- Analysis of mutation data.
- Review of treatment protocols and clinical follow-up.
Main Results:
- Monogenic defects are the primary cause of NDM presenting before six months.
- Genetic testing is crucial for predicting disease course and associated features.
- Sulfonylurea treatment can be effective for specific NDM subtypes, potentially improving neurological outcomes.
Conclusions:
- Early diagnosis and genetic analysis are vital for managing neonatal diabetes mellitus.
- Timely intervention, particularly with sulfonylureas for responsive types, can positively impact patient outcomes.
- Differentiating NDM from other causes of hyperglycemia in newborns is essential for appropriate care.
Abstract:
Neonatal diabetes mellitus is likely to be due to an underlying monogenic defect when it occurs at less than 6 months of age. Early recognition and urgent genetic testing are important for predicting the clinical course and raising awareness of possible additional features. Early treatment of sulfonylurea-responsive types of neonatal diabetes may improve neurologic outcomes. It is important to distinguish neonatal diabetes mellitus from other causes of hyperglycemia in newborns. Other causes include infection, stress, inadequate pancreatic insulin production in preterm infants, among others. This review explores the diagnostic approach, mutation types, management, and clinical course of neonatal diabetes.
More Related Videos
05:50International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure
Published on: March 12, 2020
09:31Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
Published on: January 27, 2023
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Nursing Diagnosis
The nursing diagnosis focuses on evidence-based...